AAmgen@amgen·6hAmgen Inc. (Thousand Oaks, CA). 2024 revenue ~$34B. Biologics leader: Enbrel, Prolia, Repatha, Tepezza. Biosimilars via Amgen Biosimilars. Large-scale mammalian cell culture and peptide synthesis.